Anti-MRPS12 Polyclonal Antibody Cat:K107321P Summary

Total Page：16

File Type：pdf, Size：1020Kb

Anti-MRPS12 Polyclonal Antibody Cat:K107321P Summary: 【Product name】: Anti-MRPS12 antibody 【Source】: Rabbit 【Isotype】: IgG 【Species reactivity】: Human Mouse 【Swiss Prot】: O15235 【Gene ID】: 6183 【Calculated】: MW:15kDa 【Purification】: Affinity purification 【Tested applications】: IHC 【Recommended dilution】: IHC 1:50-200. 【IHC Positive sample】: Human colorectal cancer 【Subcellular location】: Cytoplasm 【Immunogen】: A synthetic peptide of human MRPS12 【Storage】: Shipped at 4°C. Upon delivery aliquot and store at -20°C Background: Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 28S subunit protein that belongs to the ribosomal protein S12P family. The encoded protein is a key component of the ribosomal small subunit and controls the decoding fidelity and susceptibility to aminoglycoside antibiotics. The gene for mitochondrial seryl-tRNA synthetase is located upstream and adjacent to this gene, and both genes are possible candidates for the autosomal dominant deafness gene (DFNA4). Splice variants that differ in the 5' UTR have been found for this gene; all three variants encode the same protein. Sales:[email protected] For research purposes only. Tech:[email protected] Please visit www.solarbio.com for a more product information Verified picture Immunohistochemistry of paraffin-embedded Human colorectal cancer with MRPS12 antibody diluted at 1:100 Sales:[email protected] For research purposes only. Tech:[email protected] Please visit www.solarbio.com for a more product information.

Copy Link

Recommended publications

CD8 T Cell Memory Transition and Maintenance of Functional Foxo1
FoxO1 Controls Effector-to-Memory Transition and Maintenance of Functional CD8 T Cell Memory This information is current as Melba Marie Tejera, Eui Ho Kim, Jeremy A. Sullivan, Erin of October 1, 2021. H. Plisch and M. Suresh J Immunol 2013; 191:187-199; Prepublished online 3 June 2013; doi: 10.4049/jimmunol.1300331 http://www.jimmunol.org/content/191/1/187 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2013/06/03/jimmunol.130033 Material 1.DC1 http://www.jimmunol.org/ References This article cites 52 articles, 7 of which you can access for free at: http://www.jimmunol.org/content/191/1/187.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 1, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology FoxO1 Controls Effector-to-Memory Transition and Maintenance of Functional CD8 T Cell Memory Melba Marie Tejera, Eui Ho Kim, Jeremy A.
[Show full text]
1 AGING Supplementary Table 2
SUPPLEMENTARY TABLES Supplementary Table 1. Details of the eight domain chains of KIAA0101. Serial IDENTITY MAX IN COMP- INTERFACE ID POSITION RESOLUTION EXPERIMENT TYPE number START STOP SCORE IDENTITY LEX WITH CAVITY A 4D2G_D 52 - 69 52 69 100 100 2.65 Å PCNA X-RAY DIFFRACTION √ B 4D2G_E 52 - 69 52 69 100 100 2.65 Å PCNA X-RAY DIFFRACTION √ C 6EHT_D 52 - 71 52 71 100 100 3.2Å PCNA X-RAY DIFFRACTION √ D 6EHT_E 52 - 71 52 71 100 100 3.2Å PCNA X-RAY DIFFRACTION √ E 6GWS_D 41-72 41 72 100 100 3.2Å PCNA X-RAY DIFFRACTION √ F 6GWS_E 41-72 41 72 100 100 2.9Å PCNA X-RAY DIFFRACTION √ G 6GWS_F 41-72 41 72 100 100 2.9Å PCNA X-RAY DIFFRACTION √ H 6IIW_B 2-11 2 11 100 100 1.699Å UHRF1 X-RAY DIFFRACTION √ www.aging-us.com 1 AGING Supplementary Table 2. Significantly enriched gene ontology (GO) annotations (cellular components) of KIAA0101 in lung adenocarcinoma (LinkedOmics). Leading Description FDR Leading Edge Gene EdgeNum RAD51, SPC25, CCNB1, BIRC5, NCAPG, ZWINT, MAD2L1, SKA3, NUF2, BUB1B, CENPA, SKA1, AURKB, NEK2, CENPW, HJURP, NDC80, CDCA5, NCAPH, BUB1, ZWILCH, CENPK, KIF2C, AURKA, CENPN, TOP2A, CENPM, PLK1, ERCC6L, CDT1, CHEK1, SPAG5, CENPH, condensed 66 0 SPC24, NUP37, BLM, CENPE, BUB3, CDK2, FANCD2, CENPO, CENPF, BRCA1, DSN1, chromosome MKI67, NCAPG2, H2AFX, HMGB2, SUV39H1, CBX3, TUBG1, KNTC1, PPP1CC, SMC2, BANF1, NCAPD2, SKA2, NUP107, BRCA2, NUP85, ITGB3BP, SYCE2, TOPBP1, DMC1, SMC4, INCENP. RAD51, OIP5, CDK1, SPC25, CCNB1, BIRC5, NCAPG, ZWINT, MAD2L1, SKA3, NUF2, BUB1B, CENPA, SKA1, AURKB, NEK2, ESCO2, CENPW, HJURP, TTK, NDC80, CDCA5, BUB1, ZWILCH, CENPK, KIF2C, AURKA, DSCC1, CENPN, CDCA8, CENPM, PLK1, MCM6, ERCC6L, CDT1, HELLS, CHEK1, SPAG5, CENPH, PCNA, SPC24, CENPI, NUP37, FEN1, chromosomal 94 0 CENPL, BLM, KIF18A, CENPE, MCM4, BUB3, SUV39H2, MCM2, CDK2, PIF1, DNA2, region CENPO, CENPF, CHEK2, DSN1, H2AFX, MCM7, SUV39H1, MTBP, CBX3, RECQL4, KNTC1, PPP1CC, CENPP, CENPQ, PTGES3, NCAPD2, DYNLL1, SKA2, HAT1, NUP107, MCM5, MCM3, MSH2, BRCA2, NUP85, SSB, ITGB3BP, DMC1, INCENP, THOC3, XPO1, APEX1, XRCC5, KIF22, DCLRE1A, SEH1L, XRCC3, NSMCE2, RAD21.
[Show full text]
MRPS12 Rabbit Pab
Leader in Biomolecular Solutions for Life Science MRPS12 Rabbit pAb Catalog No.: A10573 Basic Information Background Catalog No. Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in A10573 protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% Observed MW protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is 14kDa reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins Calculated MW comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical 15kDa properties, which prevents easy recognition by sequence homology. This gene encodes a 28S subunit protein that belongs to the ribosomal protein S12P family. The encoded Category protein is a key component of the ribosomal small subunit and controls the decoding fidelity and susceptibility to aminoglycoside antibiotics. The gene for mitochondrial Primary antibody seryl-tRNA synthetase is located upstream and adjacent to this gene, and both genes are possible candidates for the autosomal dominant deafness gene (DFNA4). Splice Applications variants that differ in the 5' UTR have been found for this gene; all three variants encode WB,IHC the same protein. Cross-Reactivity Human Recommended Dilutions Immunogen Information WB 1:1000 - 1:2000 Gene ID Swiss Prot 6183 O15235 IHC 1:50 - 1:200 Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 30-138 of human MRPS12 (NP_203527.1). Synonyms MRPS12;MPR-S12;MT-RPS12;RPMS12;RPS12;RPSM12 Contact Product Information www.abclonal.com Source Isotype Purification Rabbit IgG Affinity purification Storage Store at -20℃.
[Show full text]
Transcriptomic and Proteomic Landscape of Mitochondrial
TOOLS AND RESOURCES Transcriptomic and proteomic landscape of mitochondrial dysfunction reveals secondary coenzyme Q deficiency in mammals Inge Ku¨ hl1,2†*, Maria Miranda1†, Ilian Atanassov3, Irina Kuznetsova4,5, Yvonne Hinze3, Arnaud Mourier6, Aleksandra Filipovska4,5, Nils-Go¨ ran Larsson1,7* 1Department of Mitochondrial Biology, Max Planck Institute for Biology of Ageing, Cologne, Germany; 2Department of Cell Biology, Institute of Integrative Biology of the Cell (I2BC) UMR9198, CEA, CNRS, Univ. Paris-Sud, Universite´ Paris-Saclay, Gif- sur-Yvette, France; 3Proteomics Core Facility, Max Planck Institute for Biology of Ageing, Cologne, Germany; 4Harry Perkins Institute of Medical Research, The University of Western Australia, Nedlands, Australia; 5School of Molecular Sciences, The University of Western Australia, Crawley, Australia; 6The Centre National de la Recherche Scientifique, Institut de Biochimie et Ge´ne´tique Cellulaires, Universite´ de Bordeaux, Bordeaux, France; 7Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden Abstract Dysfunction of the oxidative phosphorylation (OXPHOS) system is a major cause of human disease and the cellular consequences are highly complex. Here, we present comparative *For correspondence: analyses of mitochondrial proteomes, cellular transcriptomes and targeted metabolomics of five [email protected] knockout mouse strains deficient in essential factors required for mitochondrial DNA gene (IKu¨ ); expression, leading to OXPHOS dysfunction. Moreover,
[Show full text]
MRPS17 Promotes Invasion and Metastasis Through PI3K/AKT Signal
Journal of Cancer 2021, Vol. 12 4849 Ivyspring International Publisher Journal of Cancer 2021; 12(16): 4849-4861. doi: 10.7150/jca.55719 Research Paper MRPS17 promotes invasion and metastasis through PI3K/AKT signal pathway and could be potential prognostic marker for gastric cancer Wenjie Zhou1,2*, Jun Ouyang1,2*, Junqing Li1,2*, Fangjie Liu4, Tailai An1, Lvjia Cheng1,2, Zi Chong Kuo1, Changhua Zhang1 and Yulong He1,2 1. Digestive Disease Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Zhenyuan Road 628, Guangming District, Shenzhen 518000, Guangdong, China. 2. Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, Zhongshan 2nd Road 58, Yuexiu District, Guangzhou 510080, Guangdong, China. 3. Department of Pathology, The Seventh Affiliated Hospital, Sun Yat-sen University, Zhenyuan Road 628, Guangming District, Shenzhen 518000, Guangdong, China. 4. Department of Hematology, The Seventh Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan 2nd Road 58, Yuexiu District, Guangzhou 510080, Guangdong, China. 5. Scientific Research Centre, The Seventh Affiliated Hospital, Sun Yat-sen University, 628 Zhenyuan Road 628, Guangming District, Shenzhen 518000, Guangdong, China. *These authors contributed equally to this work. Corresponding authors: Changhua Zhang, E-mail: [email protected]; Yulong He, E-mail: [email protected]. © The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2020.11.10; Accepted: 2021.05.29; Published: 2021.06.11 Abstract In this study, the molecular mechanisms through which Mitochondrial Ribosomal Protein S17 (MRPS17) contributes to gastric cancer (GC) and its prognostic significance in GC have been explored.
[Show full text]
Table SI. List of Differentially Expressed Genes Detected from Three Expression Profiling Datasets GSE18842, GSE30219 and GSE33532
Table SI. List of differentially expressed genes detected from three expression profiling datasets GSE18842, GSE30219 and GSE33532. DEGs Gene Upregulated (n=428) ABCB6, ACP1, ADAM12, ADAMDEC1, ADAMTS12, AFAP1-AS1, AKR1B10, ALDH3B2, ALYREF, ANKRD22, APOBEC3B, ARG2, ARNTL2, ARTN, ASF1B, ATAD2, ATP11B, AUNIP, AURKB, BAIAP2L1, BCL11A, BIK, BIRC5, BLM, BNIP3, BORA, BUB1, BYSL, C10orf2, C12orf56, C12orf66, C15orf48, C2CD4A, C4orf46, C5orf46, CABYR, CALU, CASC7, CBX2, CCNA2, CCNE1, CCNE2, CCT2, CCT6A, CDC25A, CDC25C, CDC45, CDCA2, CDCA3, CDCA8, CDH3, CDK1, CDK5R1, CDKN2A, CDT1, CEMIP, CENPF, CENPH, CENPI, CENPK, CENPL, CENPM, CENPN, MLF1IP, CENPW, CERS6, CHAC2, CHEK1, CIART, CKAP2, CKAP2L, CKAP4, CKS1B, CNFN, COCH, COL11A1, COL3A1, COL5A1, COL5A2, CPD, CRABP2, CST1, CTSV, CTTN, CXCL13, DARS2, DBF4, DCAF13, DCUN1D1, DCUN1D5, DENND1A, DEPDC1, DEPDC1B, DEPDC7, DHFR, DIO2, DONSON, DPY19L1, DSC2, DSCC1, DSG2, DST, DTL, DUS4L, E2F7, ECT2, EGLN3, EIF4EBP1, ELOVL6, ENAH, ENO1, EPT1, ERCC6L, ERO1A, ESPL1, ESRP1, ETV4, EZH2, F12, FAM169A, FAM210A, FAM64A, FAM69A, FAM83A, FAM83D, FAM83F, FAM83H, FANCD2, FANCI, FAP, FAXC, FBXO32, FBXO45, FBXO5, FERMT1, FGF11, FHL2, FLAD1, FNDC1, FOXM1, GAL, GALNT14, GALNT2, GALNT7, GART, GCLC, GCLM, GGH, GINS3, GJB2, GJB6, GMPS, GOLM1, GPX2, GRHL1, GRTP1, GTSE1, H2AFX, HELLS, HILPDA, HIST1H2AE, HIST1H2BC, HIST1H2BH, HIST1H2BJ, HIST1H3F, HIST3H2A, HLTF, HMGA1, HMGA2, HMGB3, HOOK1, HORMAD1, HOXA10, HOXC10, HOXD10, HRASLS, HS6ST2, HSPA4L, HYLS1, IDH2, IGF2BP3, IGFBP2, IGFBP3, IGHM, IGSF9, IL4I1, IQGAP3, IRF6, ITGA11, KCNK1,
[Show full text]
Additional Tables.Xlsx
Additional Table 5 Enriched pathways of upregulated DEGs after spinal cord injury in WT (P < 0.05, q < 0.05) Database Description Ratio of DEGs Ratio of P -value P adjust q value gene name GO ribosomal subunit 87/755 214/12262 1.03E-49 4.61E-47 4.20E-47 Gm6576/Gm10036/Gm5786/Mrps28/Gm9493/Rpl13- ps3/Rpl7l1/Mrpl10/Mrpl44/Rps20/Mrpl51/Mrps11/Mpv17l2/Mrps7/Gm10020/Gm10073 /Mrpl2/Mrpl52/Rpl22/Mrpl4/Mrps24/Zcchc17/Rpl28/Mrpl34/Rpl29/Mrps36/Rpl9- ps6/Hba-a2/Hba-a1/Rpl23a- ps3/Rpl15/Rack1/Mrps18a/Mrpl28/Rpl10a/Mrpl12/Rpl18/Rpl35a/Mrpl41/Mrps12/Rpl36 a/Rps9/Rps18/Rps5/Rps27a/Rps24/Rplp2/Rpl14/Mrpl30/Rps6/Rpl6/Rps3/Rps4x/Rpsa/R pl7/Rpl27a/Rps23/Rps10/Mrps21/Rpl36/Rpl30/Rps17/Mrpl42/Rpl35/Rpl27/Rplp0/Rps28 /Rpl31/Rpl39/Rps13/Rpl13/Rps11/Rpl8/Rps3a1/Fau/Rpl9/Rpl3/Rpl26/Rps15/Rpl13a/Uba 52/Rpl24/Rpl19/Rps14/Rpl4/Rps27/Rplp1 GO ribosome 93/755 248/12262 1.67E-49 4.61E-47 4.20E-47 Gm6576/Pnpt1/Gm10036/Gm5786/Mrps28/Gm9493/Rpl13- ps3/Rpl7l1/Mrpl10/Mrpl44/Rps20/Mrpl51/Mrps11/Mpv17l2/Mrps7/Gm10020/Gm10073 /Mrpl2/Mrpl52/Rpl22/Mrpl4/Mrps24/Zcchc17/Rpl28/Mrpl34/Rpl29/Mrps36/Rpl9- ps6/Hba-a2/Hba-a1/Rpl23a- ps3/Rpl15/Rack1/Eif3h/Mrps18a/Mrpl28/Mrps33/Rpl10a/Mrpl12/Rpl18/Rpl35a/Btf3/Mrp l41/Mrps12/Rpl36a/Rps9/Rps18/Rps5/Rps27a/Rps24/Rplp2/Rpl14/Mrpl30/Rps6/Rpl6/R ps3/Rps4x/Rpsa/Rpl7/Rpl27a/Rps23/Rps10/Mrps21/Rpl36/Rpl30/Rps17/Mrpl42/Rpl35/R pl27/Rplp0/Rps28/Rpl31/Rpl39/Rps13/Rpl13/Rps11/Rpl8/Rps3a1/Fau/Rpl9/Rpl3/Rpl26/ Rps15/Rpl13a/Uba52/Rpl41/Rpl24/Rpl19/Rps14/Rpl4/Ndufa7/Rps27/Rplp1 GO structural constituent of 76/733 169/11958 1.65E-47 1.16E-44 1.12E-44 Gm6576/Gm10036/Gm5786/Rpl7l1/Mrpl10/Rps20/Mrpl51/Mrps11/Mrps7/Gm10020/G
[Show full text]
MRPS12 (NM 033362) Human Tagged ORF Clone – RC202911
OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC202911 MRPS12 (NM_033362) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: MRPS12 (NM_033362) Human Tagged ORF Clone Tag: Myc-DDK Symbol: MRPS12 Synonyms: MPR-S12; MT-RPS12; RPMS12; RPS12; RPSM12 Vector: pCMV6-Entry (PS100001) E. coli Selection: Kanamycin (25 ug/mL) Cell Selection: Neomycin ORF Nucleotide >RC202911 ORF sequence Sequence: Red=Cloning site Blue=ORF Green=Tags(s) TTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTGGATCCGGTACCGAGGAGATCTGCC GCCGCGATCGCC ATGTCCTGGTCTGGCCTTCTCCATGGCCTCAACACGTCCCTAACTTGTGGCCCAGCTCTGGTTCCCCGGC TCTGGGCTACCTGCTCCATGGCTACCCTGAACCAGATGCACCGCCTGGGGCCCCCCAAGCGGCCGCCTCG GAAGCTGGGCCCCACGGAAGGCCGGCCGCAGCTGAAGGGTGTGGTCCTGTGCACGTTTACCCGCAAGCCG AAGAAGCCCAACTCAGCCAATCGCAAGTGCTGTCGAGTGCGGCTCAGCACTGGCCGCGAGGCCGTCTGCT TCATCCCTGGGGAGGGCCACACCCTGCAGGAGCACCAGATTGTCCTTGTGGAGGGCGGCCGCACCCAGGA CCTGCCAGGCGTCAAGCTCACCGTTGTGCGTGGCAAGTACGACTGTGGCCACGTGCAGAAGAAG ACGCGTACGCGGCCGCTCGAGCAGAAACTCATCTCAGAAGAGGATCTGGCAGCAAATGATATCCTGGATT ACAAGGATGACGACGATAAGGTTTAA Protein Sequence: >RC202911 protein sequence Red=Cloning site Green=Tags(s) MSWSGLLHGLNTSLTCGPALVPRLWATCSMATLNQMHRLGPPKRPPRKLGPTEGRPQLKGVVLCTFTRKP KKPNSANRKCCRVRLSTGREAVCFIPGEGHTLQEHQIVLVEGGRTQDLPGVKLTVVRGKYDCGHVQKK TRTRPLEQKLISEEDLAANDILDYKDDDDKV Chromatograms: https://cdn.origene.com/chromatograms/mk6395_c11.zip Restriction Sites:
[Show full text]
Mitochondrial Ribosomal Proteins: Candidate Genes for Mitochondrial Disease James E
March/April 2004 ⅐ Vol. 6 ⅐ No. 2 review Mitochondrial ribosomal proteins: Candidate genes for mitochondrial disease James E. Sylvester, PhD1, Nathan Fischel-Ghodsian, MD2, Edward B. Mougey, PhD1, and Thomas W. O’Brien, PhD3 Most of the energy requirement for cell growth, differentiation, and development is met by the mitochondria in the form of ATP produced by the process of oxidative phosphorylation. Human mitochondrial DNA encodes a total of 13 proteins, all of which are essential for oxidative phosphorylation. The mRNAs for these proteins are translated on mitochondrial ribosomes. Recently, the genes for human mitochondrial ribosomal proteins (MRPs) have been identified. In this review, we summarize their refined chromosomal location. It is well known that mutations in the mitochondrial translation system, i.e., ribosomal RNA and transfer RNA cause various pathologies. In this review, we suggest possible associations between clinical conditions and MRPs based on coincidence of genetic map data and chromosomal location. These MRPs may be candidate genes for the clinical condition or may act as modifiers of existing known gene mutations (mt-tRNA, mt-rRNA, etc.). Genet Med 2004:6(2):73–80. Key Words: mitochondrial, ribosomal proteins, oxidative phosphorylation, candidate genes, translation Most of the energy requirements for cell growth, differenti- THE MITORIBOSOME ation, and development are met by the mitochondrial ATP Human cells contain two genomes and two protein synthe- produced by the process of oxidative phosphorylation. Mito- sizing (translation) systems. The first is the nuclear genome of chondrial DNA encodes 13 essential proteins of this oxidative 3 ϫ 109 bp that has 30,000 to 40,000 genes coding a much phosphorylation system.
[Show full text]
Effect of Hyperoside on Cervical Cancer Cells and Transcriptome Analysis Of
Guo et al. Cancer Cell Int (2019) 19:235 https://doi.org/10.1186/s12935-019-0953-4 Cancer Cell International PRIMARY RESEARCH Open Access Efect of hyperoside on cervical cancer cells and transcriptome analysis of diferentially expressed genes Weikang Guo1†, Hui Yu2†, Lu Zhang1, Xiuwei Chen1, Yunduo Liu1, Yaoxian Wang1* and Yunyan Zhang1* Abstract Background: Hyperoside (Hy) is a plant-derived quercetin 3-D-galactoside that exhibits inhibitory activities on vari- ous tumor types. The objective of the current study was to explore Hy efects on cervical cancer cell proliferation, and to perform a transcriptome analysis of diferentially expressed genes. Methods: Cervical cancer HeLa and C-33A cells were cultured and the efect of Hy treatment was determined using the Cell Counting Kit-8 (CCK-8) assay. After calculating the IC50 of Hy in HeLa and C-33A cells, the more sensitive to Hy treatment cell type was selected for RNA-Seq. Diferentially expressed genes (DEGs) were identifed by comparing gene expression between the Hy and control groups. Candidate genes were determined through DEG analysis, pro- tein interaction network (PPI) construction, PPI module analysis, transcription factor (TF) prediction, TF-target network construction, and survival analysis. Finally, the key candidate genes were verifed by RT-qPCR and western blot. Results: Hy inhibited HeLa and C33A cell proliferation in a dose- and time-dependent manner, as determined by the CCK-8 assay. Treatment of C-33A cells with 2 mM Hy was selected for the subsequent experiments. Compared with the control group, 754 upregulated and 509 downregulated genes were identifed after RNA-Seq.
[Show full text]
Transcriptomic Profiles of Aging in Purified Human Immune Cells
ADDITIONAL FILE 1 FOR Transcriptomic Profiles of Aging in Purified Human Immune Cells Lindsay M. Reynolds1, Jingzhong Ding2, Jackson R. Taylor3, Kurt Lohman1, Nicola Soranzo4, Alberto de la Fuente5, Tie Fu Liu2, Craig Johnson6, R. Graham Barr7, Thomas C. Register8, Kathleen M. Donohue7, Monica V. Talor9, Daniela Cihakova9, Charles Gu10, Jasmin Divers1, David Siscovick11, Gregory Burke1, Wendy Post9, Steven Shea7, David R. Jacobs, Jr.12, Ina Hoeschele13, Charles E. McCall2,14, Stephen B. Kritchevsky2,3, David Herrington2, Russell P. Tracy15, Yongmei Liu1* Table of Contents (page 1 – 2) Supplementary Figures in Additional File 1: Figure S1. Age-associations with the monocyte transcriptome (page 3) Figure S2. Correlation between co-expression network modules (page 4) Figure S3. Scatterplot of gene expression and age for genes in the ‘black’ co-expression network module (page 5) Figure S4. Correlation between MCL1 expression measured by microarray and RNA- sequencing (page 6) Figure S5. MCL1 expression measured using Western Blot (page 7) Figure S6. MRPS12 expression measured using Western Blot (page 8) Figure S7. Comparison of the effect of age on gene expression in 1,264 monocyte samples compared to results from a subset of 423 samples (page 9) Supplementary Tables in Additional File 1: Table S1. Population characteristics (page 10) Table S3. Gene set enrichment analysis for age-associated genes in monocytes from 1,264 MESA participants (page 11) 1 Table S4. Co-expression network modules associated with age (page 12) Table S14. Gene set enrichment analysis for age-associated genes in CD4+ T cells and CD14+ monocytes from 423 MESA participants (page 13) Supplementary Methods in Additional File 1: mRNA quantification using RNA seq (page 14 – 15) Supplementary References (page 16) 2 a of total Percent p-value b Figure S1.
[Show full text]
An MRPS12 Mutation Modifies Aminoglycoside
ORIGINAL RESEARCH ARTICLE published: 14 January 2015 doi: 10.3389/fgene.2014.00469 An MRPS12 mutation modiﬁes aminoglycoside sensitivity caused by 12S rRNA mutations Sonia Emperador 1,2,3, David Pacheu-Grau 1, M. Pilar Bayona-Bafaluy 1, Nuria Garrido-Pérez 1, Antonio Martín-Navarro 1, Manuel J. López-Pérez 1,2,3, Julio Montoya 1,2,3 and Eduardo Ruiz-Pesini 1,2,3,4* 1 Departamento de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza, Zaragoza, Spain 2 Instituto de Investigación Sanitaria de Aragón, Universidad de Zaragoza, Zaragoza, Spain 3 Centros de Investigación Biomédica en Red de Enfermedades Raras, Universidad de Zaragoza, Zaragoza, Spain 4 Fundación ARAID, Universidad de Zaragoza, Zaragoza, Spain Edited by: Several homoplasmic pathologic mutations in mitochondrial DNA, such as those causing Daniele Ghezzi, Foundation IRCCS Leber hereditary optic neuropathy or non-syndromic hearing loss, show incomplete Institute of Neurology C. Besta, Italy penetrance. Therefore, other elements must modify their pathogenicity. Discovery Reviewed by: of these modifying factors is not an easy task because in multifactorial diseases Niranjanan Nirmalananthan, St. George’s, University of London, UK conventional genetic approaches may not always be informative. Here, we have taken an René Massimiliano Marsano, evolutionary approach to unmask putative modifying factors for a particular homoplasmic University of Bari, Italy pathologic mutation causing aminoglycoside-induced and non-syndromic hearing loss, the *Correspondence: m.1494C>T transition in the mitochondrial DNA. The mutation is located in the decoding Eduardo Ruiz-Pesini, Departamento site of the mitochondrial ribosomal RNA. We ﬁrst looked at mammalian species that de Bioquímica, Biología Molecular y Celular, Universidad de Zaragoza.
[Show full text]